A new facility catering to bioscience, advanced pharma, innovative technologies and other high-end tenants will move ahead in Arlington.
Eden Cooper LP plans to develop a 227,000-square-foot facility for emerging industries and entrepreneurs at what are currently vacant and underutilized properties.
Construction is estimated at about $42 million for the flex-hybrid space, with the first phase set to start no later than Jan. 1, 2026.
The company asked for the Arlington Economic Development Corp. to aid with certain improvements around the site located at the corner of Eden Road and South Cooper Street.
On Tuesday, Arlington’s city council approved a one-time payment to Eden Cooper for the construction and completion of the Eden Road extension and on-site drainage improvements. The payment totals more than $3.4 million.
The project is expected to host jobs and encourage more business enterprises in Arlington, according to a city staff report.
Dallas-Fort Worth is viewed as an emerging market when it comes to life sciences real estate. According to a report from commercial real estate services firm Cushman & Wakefield, the region has an inventory pipeline expected to explode in coming years.
That is believed to be because of the relative affordability found in existing life sciences hubs, along with the increasing population and a growing number of enrollments for those pursuing life sciences degrees.
